论文部分内容阅读
日前，日本大日本制药株式会社通过中国环球律师事务所向我国的４家生产司帕沙星（ｓｐａｒｆｌｏｘａｃｉｎ）的企业提出了专利侵权警告，警告信提出上述４家公司生产的司帕沙星制剂侵犯了该公司１９８６年１０月２９日在中国申请，１９９１年授权的“含喹啉羧酸衍生物...
Japan’s Japan Dairy Pharmaceutical Co., Ltd. filed a patent infringement warning against sparfloxacin, a manufacturer of four of our country’s manufacturing firms, through its law firm China Global Law Firm, warning letter of sparfloxacin Formulation violation of the company October 29, 1986 in China, 1991 authorized "quinoline carboxylic acid derivatives ...